AMLo Biosciences

0 followers


Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.

Industries

Employees

11-50

Links

Org chart

Marie Labus
Chief Executive Officer

Marie Labus

Collapse
Penny Lovat
Chief Scientific Officer
Akhtar Husain
Chief Medical Officer
Jane Meaney
Chief Marketing Officer
Sarah Cockman
Quality Assurance & Regulatory Affairs Manager
Catherine Graham
Project Manager